CoChat

Comparative Effects of α-,β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes

Open access
Tsuchiya, Hironori · 2011 · Journal of Toxicology

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Abstract

Cigarette smoking and alcohol consumption possibly affect platelet functions. To verify the hypothesis that some α-,β-, and γ-carboline components in cigarette smoke and alcoholic beverages may change platelet aggregability, their effects on human platelets were determined by aggregometry together with investigating their membrane effects by turbidimetry. Carbolines inhibited platelet aggregation induced by five agents with the potency being 3-amino-1,4-dimethyl-5 H-pyrido[4,3-b]indole > 3-amino-1-methyl-5 H-pyrido[4,3-b]indole > 1-methyl-9 H-pyrido[3,4-b]indole. The most potent 3-amino-1,4-dimethyl-5 H-pyrido[4,3-b]indole showed 50% aggregation-inhibitory concentrations of 6–172 μ M. Both γ-carbolines interacted with phosphatidylcholine membranes to lower the lipid phase transition temperature with the potency correlating to the antiplatelet activity, suggesting that the interaction with platelet membranes to increase their fluidity underlies antiplatelet effects. Given their possible concentration and accumulation in platelets,γ- and β-carbolines would provide cigarette smokers and alcohol drinkers with reduced platelet aggregability, and they may be responsible for the occurrence of hemorrhagic diseases associated with heavy smoking and alcoholics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2011/151596

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The structures of α-, β-, and γ-carbolines tested in this study.
Figure 1 The structures of α-, β-, and γ-carbolines tested in this study.CC BY · PubMed Central
Figure 2 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to collagen. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).
Figure 2 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to collagen. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).CC BY · PubMed Central
Figure 3 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to PAF. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).
Figure 3 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to PAF. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).CC BY · PubMed Central
Figure 4 Concentrations of carbolines to produce 50% inhibition of the first phase platelet aggregation responses (T max, AUC, and slope) to epinephrine. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).
Figure 4 Concentrations of carbolines to produce 50% inhibition of the first phase platelet aggregation responses (T max, AUC, and slope) to epinephrine. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).CC BY · PubMed Central
Figure 5 Concentrations of carbolines to produce 50% inhibition of the second phase platelet aggregation responses (T max, AUC, and slope) to epinephrine. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).
Figure 5 Concentrations of carbolines to produce 50% inhibition of the second phase platelet aggregation responses (T max, AUC, and slope) to epinephrine. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).CC BY · PubMed Central
Figure 6 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to ADP. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).
Figure 6 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to ADP. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).CC BY · PubMed Central
Figure 7 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to thrombin. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).
Figure 7 Concentrations of carbolines to produce 50% inhibition of the platelet aggregation responses (T max, AUC, and slope) to thrombin. N: Not inhibited by 50% at the indicated concentrations. Data are presented as mean ± SE (n = 7).CC BY · PubMed Central
Figure 8 Effects of antiplatelet γ-carboline on membrane DPPC phase transition. The absorbance of DPPC liposome suspensions treated with 0, 0.5, 1, or 1.5 mM ADγC was measured at 450 nm with increasing the temperature. Typical traces in multiple measurements are shown.
Figure 8 Effects of antiplatelet γ-carboline on membrane DPPC phase transition. The absorbance of DPPC liposome suspensions treated with 0, 0.5, 1, or 1.5 mM ADγC was measured at 450 nm with increasing the temperature. Typical traces in multiple measurements are shown.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Research works printed but not linked: 4

  1. 1999, Alcoholism: Clinical and Experimental Research, 23, 1114, 10.1111/j.1530-0277.1999.tb04234.x · doi:10.1111/j.1530-0277.1999.tb04234.x · Paper page
  2. 2008, Natural Product Communications, 3, 809
  3. 1988, Journal of Clinical Chemistry and Clinical Biochemistry, 26, 265
  4. 2006, Alcohol Research and Health, 29, 199

Cited by

See all 11

Metadata

Authors
Tsuchiya, H.
Affiliations
Asahi University (JP)
Corresponding author
Tsuchiya, Hironori
Venue
Journal of Toxicology
Publisher
Wiley
Published
2011
Volume
2011
Pages
1-9
ISSN
  • 1687-8191 (ISSN-L)
  • 1687-8205
OpenAlex
W2042424272
Cited by
8
References
80
Citations by year
2022: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 1
FWCI
0.44
Type
journal article
Language
en
Open access
Locations
  • Journal of Toxicology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Japan Society for the Promotion of Science (23593005)
  • San-Ei Gen Foundation for Food Chemical Research (23593005)
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
carbolines, platelet aggregation, antiplatelet activity, cigarette smoke, alcohol consumption, Trp-P-1, 3-amino-1-methyl-5H-pyrido[4,3-b]indole, phosphatidylcholine membranes, lipid phase transition temperature, membrane fluidity, hemorrhagic disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Effects of α-,β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes. https://app.cochat.ai/papers/10.1155/2011/151596
The paper
Tsuchiya, H. (2011). Comparative Effects of α-,β-, and γ-Carbolines on Platelet Aggregation and Lipid Membranes. Journal of Toxicology. https://doi.org/10.1155/2011/151596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.